MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Intermediate CAG repeat length in the HTT gene and comorbidity – The SHAPE Study (Swedish-Huntingtin-Alleles-and-PhenotypE)

M. Ghazarian, E. Stattin, J. Sundblom, V. Niemelä (Uppsala, Sweden)

Meeting: 2019 International Congress

Abstract Number: 33

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Genetics

Session Information

Date: Monday, September 23, 2019

Session Title: Huntington’s Disease

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To 1) determine the distribution of CAG repeats of the Huntingtin gene in a Swedish general population sample, 2) explore the phenotype caused by specific CAG repeat numbers, with focus on the Intermediate Alleles (IA, 27-35 repeats).

Background: Behavioral symptoms have been attributed to carrying IAs. However, these findings come from Huntington’s disease families and confounding by genetic modifiers cannot be ruled out.

Method: DNA-samples from 8272 individuals were retrieved from a study of first-ever myocardial infarction (MI), thus without connection to HD. Each MI case was (age- and sex-) matched with two controls from the medical biobank of Umeå University Hospital. Baseline self-assessed health and demographic data was collected from participants of the MI-study cohort.

Results: CAG-repeat numbers of 7387 individuals were successfully measured of which 503 subjects (6.8%) were IA-carriers, 30 subjects (0.4%) had a reduced penetrance allele (36-39 repeats), and 2 individuals had a full penetrance allele (>39 repeats). In brief, self-assessed health ratings between carriers of IAs vs. normal alleles did not differ. The analysis was limited by incomplete data on some of the questionnaires.

Conclusion: This population has among the highest ever reported prevalences of IAs and numerically includes the largest single cohort of IAs to date The frequency of reduced penetrance alleles was surprisingly high, 1/250 individuals. While self-assessed health does not seem to depend on carrying IAs, a future national registry-based study of this cohort aims to clarify if IA carriers have excess psychiatric comorbidity.

To cite this abstract in AMA style:

M. Ghazarian, E. Stattin, J. Sundblom, V. Niemelä. Intermediate CAG repeat length in the HTT gene and comorbidity – The SHAPE Study (Swedish-Huntingtin-Alleles-and-PhenotypE) [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/intermediate-cag-repeat-length-in-the-htt-gene-and-comorbidity-the-shape-study-swedish-huntingtin-alleles-and-phenotype/. Accessed May 12, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/intermediate-cag-repeat-length-in-the-htt-gene-and-comorbidity-the-shape-study-swedish-huntingtin-alleles-and-phenotype/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley